Vectura Group Limited - Company Profile and SWOT Analysis
Summary
Vectura Group Limited - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Vectura Group Limited (Vectura or 'the company') is engaged in the development of pharmaceutical therapies for the treatment of airways-related diseases. The company develops inhalation products to diseases such as obstructive pulmonary disease (COPD), cystic fibrosis, asthma, chronic pulmonary fibrosis, and other diseases. It offers dry powder inhalers (DPIs), pressurized metered dose inhalers (pMDI) and smart nebulizer delivery systems. The group's portfolio is comprised of partnered and licensed marketed products as well as branded and generic investigational drugs. Vectura operates in the US, the UK, and other European countries including France, Germany, and Switzerland. The company is headquartered in Chippenham, Wiltshire, the UK.
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook